Back
Revance Therapeutics Vs. NovaBay Pharmaceuticals Industry Stock Comparison
Sell
21
RVNC
Revance Therapeutics
Last Price:
5.86
Seasonality Move:
-5.59%
Sell
26
NBY
NovaBay Pharmaceuticals
Last Price:
0.50
Seasonality Move:
-14.79%
Sell
21
Revance Therapeutics (RVNC)
is a Sell
Is Revance Therapeutics a Buy, Sell or Hold?
- The current Revance Therapeutics [RVNC] share price is $5.99. The Score for RVNC is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.
- RVNC is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
26
NovaBay Pharmaceuticals (NBY)
is a Sell
Is NovaBay Pharmaceuticals a Buy, Sell or Hold?
- The current NovaBay Pharmaceuticals [NBY] share price is $0.51. The Score for NBY is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
- NBY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
RVNC Stock Price Chart
What is Revance Therapeutics's stock price today?
-
The Revance Therapeutics share price today is $5.99
The current trend is moderately bearish and RVNC is experiencing selling pressure, which indicates risk of future bearish movement.
NBY Stock Price Chart
What is NovaBay Pharmaceuticals's stock price today?
-
The NovaBay Pharmaceuticals share price today is $0.51
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBY is experiencing slight selling pressure.
RVNC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.25 | Buy |
Relative Strength Index (14 RSI): | 48.82 | Sell |
Chaikin Money Flow: | -2917555 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (6.31 - 6.71) | Sell |
Bollinger Bands (100): | (2.57 - 5.65) | Buy |
NBY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.1 | Sell |
Relative Strength Index (14 RSI): | 38.38 | Sell |
Chaikin Money Flow: | -38478 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.47 - 0.53) | Buy |
Bollinger Bands (100): | (0.61 - 3.39) | Sell |
RVNC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 6.35 | Sell |
20-day SMA: | 6.49 | Sell |
50-day SMA: | 5.16 | Buy |
200-day SMA: | 5.05 | Buy |
8-day EMA: | 6.25 | Sell |
20-day EMA: | 6.21 | Sell |
50-day EMA: | 5.42 | Buy |
200-day EMA: | 6.59 | Sell |
NBY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.48 | Buy |
20-day SMA: | 0.49 | Buy |
50-day SMA: | 0.89 | Sell |
200-day SMA: | 3.84 | Sell |
8-day EMA: | 0.49 | Buy |
20-day EMA: | 0.53 | Sell |
50-day EMA: | 0.97 | Sell |
200-day EMA: | 8.42 | Sell |
Revance Therapeutics Earnings Growth & RVNC Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.54 per share, an increase next quarter of $0.40 per share, an increase this year of $2.64 per share, and an increase next year of $0.70 per share.
NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates
- Analysts estimate an earnings increase this quarter of $13.87 per share, an increase next quarter of $0.05 per share, an increase this year of $78.20 per share, and an increase next year of $1.81 per share.
Revance Therapeutics Technical Analysis
Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
NovaBay Pharmaceuticals Technical Analysis
Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |